FTC case against insulin price gouging halted after commissioners fired by Trump

FTC seal

A Federal Trade Commission (FTC) case against insulin price gouging has come to a screeching halt after two Democratic commissioners were fired by President Donald Trump.

On March 31, the FTC stayed its suit against pharmacy middle managers, called pharmacy benefit managers (PBMs). Government investigations, including one by the FTC, have pointed to PBMs, as behind at least part of the high prices.

The FTC said in its order that the case couldn’t move ahead because the remaining two Republican commissioners had recused themselves.

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP                                             CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.